ClinicalTrials.Veeva

Menu
Q

Queen Anne Street Medical Centre | London, UK

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Astegolimab
GDC-6599
RO7790121
UPB-101

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 7 total trials
Locations recently updated

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease (SIBERITE-1)

This Phase III, multicenter, double-blind, placebo-controlled treat-through study will evaluate the efficacy and safety of induction and maintenance...

Enrolling
Moderately to Severely Active Crohns Disease
Drug: Placebo
Drug: Afimkibart

A Randomized, Double-blind, Placebo-controlled, Multiple Dose-Ranging Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic...

Enrolling
COPD
Other: Placebo
Biological: Biological: Solrikitug high dose
Locations recently updated

The purpose of this study is to assess the long-term safety and to explore the efficacy of astegolimab in participants with chronic obstructive pulmo...

Enrolling
Chronic Obstructive Pulmonary Disease
Drug: Astegolimab

Trial sponsors

Genentech logo
Roche logo
T
U
U

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems